siRNA treatment reduces triglycerides in individuals with unusual health condition

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran lessened triglyceride amounts through 80% as well as lowered the risk of pancreatitis in individuals along with relentless chylomicronemia, with or without a genetic prognosis.